Cargando…

Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation

BACKGROUND: High blood pressure is one of the most common reasons why patients seek assistance in daily clinical practice. Screening for hypertension is fundamental and, because hypertension is identified only when blood pressure is measured, accurate measurements are key to the diagnosis and manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazoteras-Pardo, Victoria, Becerro-De-Bengoa-Vallejo, Ricardo, Losa-Iglesias, Marta Elena, López-López, Daniel, Palomo-López, Patricia, Rodríguez-Sanz, David, Calvo-Lobo, César
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444211/
https://www.ncbi.nlm.nih.gov/pubmed/30888331
http://dx.doi.org/10.2196/13137
_version_ 1783407987234177024
author Mazoteras-Pardo, Victoria
Becerro-De-Bengoa-Vallejo, Ricardo
Losa-Iglesias, Marta Elena
López-López, Daniel
Palomo-López, Patricia
Rodríguez-Sanz, David
Calvo-Lobo, César
author_facet Mazoteras-Pardo, Victoria
Becerro-De-Bengoa-Vallejo, Ricardo
Losa-Iglesias, Marta Elena
López-López, Daniel
Palomo-López, Patricia
Rodríguez-Sanz, David
Calvo-Lobo, César
author_sort Mazoteras-Pardo, Victoria
collection PubMed
description BACKGROUND: High blood pressure is one of the most common reasons why patients seek assistance in daily clinical practice. Screening for hypertension is fundamental and, because hypertension is identified only when blood pressure is measured, accurate measurements are key to the diagnosis and management of this disease. The European Society of Hypertension International Protocol revision 2010 (ESH-IP2) was developed to assess the validity of automatic blood pressure measuring devices that are increasingly being used to replace mercury sphygmomanometers. OBJECTIVE: We sought to determine whether the iHealth Track blood pressure monitor meets ESH-IP2 requirements for self-measurement of blood pressure and heart rate at the brachial level and is appropriate for use in the general population. METHODS: This study was a descriptive investigation. ESH-IP2 requires a total number of 33 participants. For each measure, the difference between observer and device blood pressure and heart rate values is calculated. In all, 99 pairs of blood pressure differences are classified into 3 categories (≤5, ≤10, and ≤15 mm Hg), and 99 pairs of heart rate differences are classified into 3 categories (≤3, ≤5, and ≤8 beats/min). We followed these protocol procedures in a convenience sample of 33 participants. RESULTS: iHealth Track fulfilled ESH-IP2 requirements and passed the validation process successfully. We observed an absolute difference within 5 mm Hg in 75 of 99 comparisons for systolic blood pressure, 78 of 99 comparisons for diastolic blood pressure, and 89 of 99 comparisons for heart rate. The mean differences between the test and standard readings were 4.19 (SD 4.48) mm Hg for systolic blood pressure, 3.74 (SD 4.55) mm Hg for diastolic blood pressure, and 1.95 (SD 3.27) beats/min for heart rate. With regard to part 2 of ESH-IP2, we observed a minimum of 2 of 3 measurements within a 5-mm Hg difference in 29 of 33 participants for systolic blood pressure and 26 of 33 for diastolic blood pressure, and a minimum of 2 of 3 measurements within a 3-beat/min difference in 30 of 33 participants for heart rate. CONCLUSIONS: iHealth Track readings differed from the standard by less than 5, 10, and 15 mm Hg, fulfilling ESH-IP2 requirements. Consequently, this device is suitable for use in the general population.
format Online
Article
Text
id pubmed-6444211
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-64442112019-04-17 Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation Mazoteras-Pardo, Victoria Becerro-De-Bengoa-Vallejo, Ricardo Losa-Iglesias, Marta Elena López-López, Daniel Palomo-López, Patricia Rodríguez-Sanz, David Calvo-Lobo, César JMIR Mhealth Uhealth Original Paper BACKGROUND: High blood pressure is one of the most common reasons why patients seek assistance in daily clinical practice. Screening for hypertension is fundamental and, because hypertension is identified only when blood pressure is measured, accurate measurements are key to the diagnosis and management of this disease. The European Society of Hypertension International Protocol revision 2010 (ESH-IP2) was developed to assess the validity of automatic blood pressure measuring devices that are increasingly being used to replace mercury sphygmomanometers. OBJECTIVE: We sought to determine whether the iHealth Track blood pressure monitor meets ESH-IP2 requirements for self-measurement of blood pressure and heart rate at the brachial level and is appropriate for use in the general population. METHODS: This study was a descriptive investigation. ESH-IP2 requires a total number of 33 participants. For each measure, the difference between observer and device blood pressure and heart rate values is calculated. In all, 99 pairs of blood pressure differences are classified into 3 categories (≤5, ≤10, and ≤15 mm Hg), and 99 pairs of heart rate differences are classified into 3 categories (≤3, ≤5, and ≤8 beats/min). We followed these protocol procedures in a convenience sample of 33 participants. RESULTS: iHealth Track fulfilled ESH-IP2 requirements and passed the validation process successfully. We observed an absolute difference within 5 mm Hg in 75 of 99 comparisons for systolic blood pressure, 78 of 99 comparisons for diastolic blood pressure, and 89 of 99 comparisons for heart rate. The mean differences between the test and standard readings were 4.19 (SD 4.48) mm Hg for systolic blood pressure, 3.74 (SD 4.55) mm Hg for diastolic blood pressure, and 1.95 (SD 3.27) beats/min for heart rate. With regard to part 2 of ESH-IP2, we observed a minimum of 2 of 3 measurements within a 5-mm Hg difference in 29 of 33 participants for systolic blood pressure and 26 of 33 for diastolic blood pressure, and a minimum of 2 of 3 measurements within a 3-beat/min difference in 30 of 33 participants for heart rate. CONCLUSIONS: iHealth Track readings differed from the standard by less than 5, 10, and 15 mm Hg, fulfilling ESH-IP2 requirements. Consequently, this device is suitable for use in the general population. JMIR Publications 2019-03-19 /pmc/articles/PMC6444211/ /pubmed/30888331 http://dx.doi.org/10.2196/13137 Text en ©Victoria Mazoteras-Pardo, Ricardo Becerro-De-Bengoa-Vallejo, Marta Elena Losa-Iglesias, Daniel López-López, Patricia Palomo-López, David Rodríguez-Sanz, César Calvo-Lobo. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 19.03.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Mazoteras-Pardo, Victoria
Becerro-De-Bengoa-Vallejo, Ricardo
Losa-Iglesias, Marta Elena
López-López, Daniel
Palomo-López, Patricia
Rodríguez-Sanz, David
Calvo-Lobo, César
Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation
title Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation
title_full Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation
title_fullStr Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation
title_full_unstemmed Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation
title_short Validation in the General Population of the iHealth Track Blood Pressure Monitor for Self-Measurement According to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation
title_sort validation in the general population of the ihealth track blood pressure monitor for self-measurement according to the european society of hypertension international protocol revision 2010: descriptive investigation
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444211/
https://www.ncbi.nlm.nih.gov/pubmed/30888331
http://dx.doi.org/10.2196/13137
work_keys_str_mv AT mazoteraspardovictoria validationinthegeneralpopulationoftheihealthtrackbloodpressuremonitorforselfmeasurementaccordingtotheeuropeansocietyofhypertensioninternationalprotocolrevision2010descriptiveinvestigation
AT becerrodebengoavallejoricardo validationinthegeneralpopulationoftheihealthtrackbloodpressuremonitorforselfmeasurementaccordingtotheeuropeansocietyofhypertensioninternationalprotocolrevision2010descriptiveinvestigation
AT losaiglesiasmartaelena validationinthegeneralpopulationoftheihealthtrackbloodpressuremonitorforselfmeasurementaccordingtotheeuropeansocietyofhypertensioninternationalprotocolrevision2010descriptiveinvestigation
AT lopezlopezdaniel validationinthegeneralpopulationoftheihealthtrackbloodpressuremonitorforselfmeasurementaccordingtotheeuropeansocietyofhypertensioninternationalprotocolrevision2010descriptiveinvestigation
AT palomolopezpatricia validationinthegeneralpopulationoftheihealthtrackbloodpressuremonitorforselfmeasurementaccordingtotheeuropeansocietyofhypertensioninternationalprotocolrevision2010descriptiveinvestigation
AT rodriguezsanzdavid validationinthegeneralpopulationoftheihealthtrackbloodpressuremonitorforselfmeasurementaccordingtotheeuropeansocietyofhypertensioninternationalprotocolrevision2010descriptiveinvestigation
AT calvolobocesar validationinthegeneralpopulationoftheihealthtrackbloodpressuremonitorforselfmeasurementaccordingtotheeuropeansocietyofhypertensioninternationalprotocolrevision2010descriptiveinvestigation